2020 annual financial data
Lexaria Bioscience 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -681.01%.
Operating income was -4,148,797 USD and net income was -3,933,996 USD.
Operating cash flow was -2,618,785 USD.
Get free Lexaria Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 384,543 USD
- Operating income
- -4,148,797 USD
- Net income
- -3,933,996 USD
- Operating cash flow
- -2,618,785 USD